Farallon Capital Management, L.L.C. / BSX
Farallon Capital Management, L.L.C.’s Boston Scientific Corp Position
Does Farallon Capital Management, L.L.C. own Boston Scientific Corp (BSX)? Yes — 7.47M shares worth $469M (+2.54% of its 13F portfolio) as of Q1 2026, up from 7.44M shares the prior filed quarter.
Position Value
$469M
Q1 2026
Shares
7.47M
% of Portfolio
+2.54%
Quarters Held
23
currently held
Position History BSX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 7.47M | $469M | +2.54% |
| Q4 2025 | 7.44M | $709M | +3.35% |
| Q3 2025 | 4.75M | $463M | +1.90% |
| Q2 2025 | 3.98M | $428M | +1.80% |
| Q1 2025 | 3.76M | $380M | +2.03% |
| Q4 2024 | 5.02M | $449M | +2.28% |
| Q3 2024 | 5.43M | $455M | +2.21% |
| Q2 2024 | 4.11M | $316M | +1.49% |
| Q1 2024 | 4.60M | $315M | +1.43% |
| Q4 2023 | 5.82M | $336M | +1.47% |
| Q3 2023 | 5.04M | $266M | +1.14% |
| Q2 2023 | 5.05M | $273M | +1.52% |
| Q1 2023 | 7.71M | $385M | +1.90% |
| Q4 2022 | 9.26M | $428M | +2.81% |
| Q3 2022 | 12.15M | $471M | +2.58% |
| Q2 2022 | 15.05M | $561M | +3.17% |
| Q1 2022 | 15.74M | $697M | +3.06% |
| Q4 2021 | 16.81M | $714M | +3.70% |
| Q3 2021 | 14.00M | $608M | +2.93% |
| Q2 2021 | 12.72M | $544M | +2.24% |
| Q1 2021 | 12.82M | $496M | +2.75% |
| Q4 2020 | 13.24M | $476M | +3.04% |
| Q3 2020 | 8.28M | $316M | +2.21% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Farallon Capital Management, L.L.C.’s full portfolio or all institutional holders of BSX.